ARNA Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 jan 1970 @ 01:00):

Arena Pharmaceuticals, Inc., a biopharmaceutical company, focuses on providing novel medicines with pharmacology and pharmacokinetics to patients worldwide...

Stats
Dagens volum	0.00
Gjennomsnittsvolum	1.47M
Markedsverdi	0.00
EPS	$0 ( 2022-05-04 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-9.86
ATR14	$1.142 (1.14%)

Insider Trading

Date	Person	Action	Amount	type
2022-03-11	Nova Tina Susan	Sell	17 776	Common Stock
2022-03-11	Nova Tina Susan	Sell	3 067	Common Stock
2022-03-11	Nova Tina Susan	Sell	4 800	Stock Option (right to buy)
2022-03-11	Nova Tina Susan	Sell	15 000	Stock Option (right to buy)
2022-03-11	Nova Tina Susan	Sell	5 000	Stock Option (right to buy)

INSIDER POWER
0.00
Last 100 transactions
Buy: 416 073 \| Sell: 1 553 839

Volum Korrelasjon

Lang: 0.35 (neutral)

Kort: 0.92 (very strong)

Signal:(78.914) Expect same movement, but be aware

Arena Pharmaceuticals Inc Korrelasjon

10 Mest positive korrelasjoner
LWAC	0.991
ARCE	0.962
SRAC	0.943
DSKE	0.933
FANH	0.918
MYRG	0.914
MRM	0.91
TSBK	0.91
TIG	0.908
NESR	0.908

10 Mest negative korrelasjoner
NKTR	-0.97
BXRX	-0.969
AGLE	-0.968
INGN	-0.964
BJDX	-0.954
FULC	-0.95
SMSI	-0.947
UPLD	-0.945
ZI	-0.937
CCSI	-0.936

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Arena Pharmaceuticals Inc Korrelasjon - Valuta/Råvare

0.42
( neutral )

0.63
( weak )

-0.30
( neutral )

0.30
( neutral )

-0.46
( neutral )

-0.68
( moderate negative )

Arena Pharmaceuticals Inc Økonomi

Annual	2021
Omsetning:	$54 000.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-11.26

FY	2021
Omsetning:	$54 000.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-11.26

FY	2020
Omsetning:	$319 000
Bruttogevinst:	$319 000 (100.00 %)
EPS:	$-7.39

FY	2019
Omsetning:	$806.43M
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$7.99

Financial Reports:

No articles found.

Arena Pharmaceuticals Inc

Arena Pharmaceuticals, Inc., a biopharmaceutical company, focuses on providing novel medicines with pharmacology and pharmacokinetics to patients worldwide. The company's investigational clinical programs include Etrasimod (APD334) that is in Phase III clinical trial for ulcerative colitis, Phase IIb/III clinical trial for Crohn's disease, Phase II clinical trial for alopecia areata, Phase III clinical trial for atopic dermatitis, and Phase IIb clinical trial for eosinophilic esophagitis; Olorinab (APD371), which is in Phase IIb clinical trial for the treatment of abdominal pain associated with irritable bowel syndrome; APD418 that is in Phase II clinical trial for acute heart failure; and Temanogrel for coronary microvascular obstruction that is in Phase II clinical trial. It also develops ralinepag (APD811), which is in Phase III clinical trial for pulmonary arterial hypertension. The company has collaboration agreements with United Therapeutics Corporation; Everest Medicines Limited; Eisai Co., Ltd. and Eisai Inc.; Boehringer Ingelheim International GmbH; Beacon Discovery, Inc.; and Aristea Therapeutics, Inc. Arena Pharmaceuticals, Inc. was incorporated in 1997 and is based in Park City, Utah. As of March 11, 2022, Arena Pharmaceuticals, Inc. operates as a subsidiary of Pfizer Inc.